Evidence map›Paper›PMID 42839961›Full record

ArticleFrontiers in epigenetics and epigenomics2025

Editorial: Current insights in Epigenetics and Epigenomics.

Steven Henikoff, Sharon Y R Dent, Raul Mostoslavsky, Ting Wang, Luca Comai

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in epigenetics and epigenomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Steven HenikoffBasic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Sharon Y R DentDepartment of Epigenetics and Molecular Carcinogenesis and Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Raul MostoslavskyThe Krantz Family Center for Cancer Research, The Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, United States.
Ting WangDepartment of Genetics, Washington University in St. Louis, St. Louis, MO, United States.
Luca ComaiDepartment of Plant Biology, University of California, Davis, Davis, CA, United States.

Funding

A novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancerR01CA279173 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Raul Mostoslavsky · 2024 to 2026
$2.4M
NCI NIH HHS R01 CA279173
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chromatinDNA methylationenvironmentEpigeneticsEpigenomics

Identifiers

PMID42839961
PMCPMC13632475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.